Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLIN.L Share News (CLIN)

  • There is currently no data for CLIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Deutsche Bank cuts Unilever and Britvic to Hold

Thu, 16th Sep 2021 09:53

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

----------

FTSE 100

----------

EXANE BNP RAISES STANDARD CHARTERED TO 'NEUTRAL' (UNDERPERFORM)

----------

DEUTSCHE BANK CUTS SHELL PRICE TARGET TO 1,871 (1,937) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES BP PRICE TARGET TO 320 (313) PENCE - 'HOLD'

----------

DEUTSCHE BANK CUTS ANGLO AMERICAN PRICE TARGET TO 3,600 (3,700) PENCE - 'BUY'

----------

DEUTSCHE BANK CUTS ANTOFAGASTA PRICE TARGET TO 1,310 (1,320) PENCE - 'HOLD'

----------

DEUTSCHE BANK CUTS RIO TINTO PRICE TARGET TO 6,000 (6,600) PENCE - 'HOLD'

----------

DEUTSCHE BANK CUTS BHP GROUP PRICE TARGET TO 2,200 (2,400) PENCE - 'HOLD'

----------

DEUTSCHE BANK RAISES GLENCORE PRICE TARGET TO 440 (420) PENCE - 'BUY'

----------

RBC RAISES GLENCORE PRICE TARGET TO 400 (360) PENCE - 'OUTPERFORM'

----------

GOLDMAN RAISES GLENCORE PRICE TARGET TO 430 (390) PENCE - 'BUY'

----------

DEUTSCHE BANK CUTS UNILEVER TO 'HOLD' (BUY) - PRICE TARGET 4,600 (4,800) PENCE

----------

JPMORGAN RAISES JD SPORTS FASHION TARGET TO 1,350 (1,300) PENCE - 'OVERWEIGHT'

----------

FTSE 250

----------

CREDIT SUISSE RAISES REDROW PRICE TARGET TO 745 (640) PENCE - 'OUTPERFORM'

----------

DEUTSCHE BANK RAISES REDROW PRICE TARGET TO 800 (673) PENCE - 'BUY'

----------

BARCLAYS RAISES REDROW PRICE TARGET TO 820 (810) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES REDROW PRICE TARGET TO 850 (790) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES DRAX GROUP PRICE TARGET TO 960 (550) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES VESUVIUS PRICE TARGET TO 760 (685) PENCE - 'BUY'

----------

DEUTSCHE BANK CUTS BRITVIC TO 'HOLD' ('BUY') - TARGET 950 PENCE

----------

BERENBERG RAISES TRUSTPILOT PRICE TARGET TO 440 (430) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

CITIGROUP RAISES SOUTH32 PRICE TARGET TO 200 (185) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES SOUTH32 PRICE TARGET TO 195 (165) PENCE - 'HOLD'

----------

BERENBERG CUTS PAN AFRICAN RESOURCES PRICE TARGET TO 25 (29) PENCE - 'BUY'

----------

RBC CUTS CLINIGEN PRICE TARGET TO 860 (935) PENCE - 'OUTPERFORM'

----------

BARCLAYS RAISES KEYWORDS STUDIOS TARGET TO 3,550 (3,200) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES KEYWORDS STUDIOS PRICE TARGET TO 3,700 (3,450) PENCE - 'BUY'

----------

BARCLAYS CUTS FEVERTREE DRINKS PRICE TARGET TO 2,400 (2,500) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES FEVERTREE DRINKS PRICE TARGET TO 2,200 (2,100) PENCE - 'HOLD'

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
8 Dec 2021 08:16

Clinigen to be taken private by Triton in £1.2bn deal, shares surge

(Sharecast News) - Clinigen surged on Wednesday after agreeing to be taken private by European investment firm Triton in a £1.2bn deal.

Read more
2 Dec 2021 14:28

Shares in Clinigen surge on takeover talks with Triton Investment

Shares in Clinigen surge on takeover talks with Triton Investment

Read more
2 Dec 2021 12:59

Clinigen confirms takeover talks with Triton, shares surge

(Sharecast News) - Clinigen shares surged on Thursday after the company confirmed it has received a non-binding indicative proposal from investment firm Triton about a possible offer.

Read more
2 Dec 2021 09:52

LONDON BROKER RATINGS: Upgrades for Old Mutual and Superdry; Drax cut

LONDON BROKER RATINGS: Upgrades for Old Mutual and Superdry; Drax cut

Read more
1 Dec 2021 13:42

Clinigen's leukaemia treatment Erwinase fails to gain approval in US

Clinigen's leukaemia treatment Erwinase fails to gain approval in US

Read more
29 Nov 2021 11:21

Clinigen signs exclusive agreement with Nippon Shinyaku on Viltepso

Clinigen signs exclusive agreement with Nippon Shinyaku on Viltepso

Read more
25 Nov 2021 16:01

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
17 Nov 2021 16:01

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
5 Nov 2021 09:55

Liberum lowers target price on Clinigen

(Sharecast News) - Analysts at Liberum lowered their target price on pharmaceutical services and products group Clinigen from 886.0p to 800.0p on Friday but stated risks still appeared to be "skewed to the upside".

Read more
8 Oct 2021 08:46

Clinigen and Humanigen partner to progress investigational Covid drug

Clinigen and Humanigen partner to progress investigational Covid drug

Read more
22 Sep 2021 19:31

TRADING UPDATES: Clinigen signs Copiktra deal; Alien "really pleased"

TRADING UPDATES: Clinigen signs Copiktra deal; Alien "really pleased"

Read more
22 Sep 2021 13:34

Clinigen to distribute 'Copiktra' in most of Europe

(Sharecast News) - Pharmaceutical products and services provider Clinigen has signed an exclusive agreement with Secura Bio for the supply and distribution of 'Copiktra' in most of Europe, it announced on Wednesday.

Read more
16 Sep 2021 12:29

Clinigen cuts full-year earnings forecasts, shares fall

(Sharecast News) - Shares in Clinigen Group fell on Thursday after the pharmaceuticals specialist cut its full-year earnings forecast.

Read more
16 Sep 2021 12:07

Clinigen shares fall on lowered outlook as profit more than doubles

Clinigen shares fall on lowered outlook as profit more than doubles

Read more
16 Sep 2021 10:55

AIM WINNERS & LOSERS: Kibo invests in Eqtec project; Clinigen falls

AIM WINNERS & LOSERS: Kibo invests in Eqtec project; Clinigen falls

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.